It may be impossible to ever know if a true bottom has ever been seen, but many investors love finding great companies where they feel that a sell-off has overly punished the…
Illumina reported mixed second-quarter financial results on Wednesday before the markets opened.
Chris Lange Wednesday's top analyst upgrades, downgrades and initiations include Apple, Exxon Mobil, LifeLock, Microsoft, PayPal and Chipotle Mexican Grill.
Earnings season is hitting its stride next week, and the health care sector, the biotech stocks in particular, have been on a roll for the past 12 months.
Friday's top analyst upgrades, downgrades and initiations include Bank of America, Google, Intel, Fairchild Semiconductor, Mobileye and National Oilwell Varco.
Thursday's top analyst upgrades, downgrades and initiations include Atmel, BlackBerry, Cisco Systems, Ctrip.com International, CarMax and AOL.
It seems as though every single investor is still in love with Apple. But is it the best stock with the most upside of all stocks in the market?
A new research report from Cowen features three top stocks of companies that exceeded earnings estimates that the firm feels should be bought now.
Tuesday's top analyst upgrades and downgrades include AcelRx Pharmaceuticals, AECOM, Electronic Arts, Hewlett-Packard, Myriad Genetics and Urban Outfitters.
24/7 Wall St. reviewed the new Credit Suisse Top Picks for 2015 report, and here are five of the top health care picks.
A new research report from the analysts at Cowen highlights the firm's top health care picks, many of which have some huge upside potential to the posted price targets.
With the bull market nearing six years old, 24/7 Wall St. has identified 11 large and well-known stocks that are valued at over 50 times earnings.
A new report from Cowen makes the case that a blood test that detects evidence of cancer in the circulation could soon replace the older more traditional biopsy methods.
ThinkstockIllumina Inc. (NASDAQ: ILMN) reported its earnings before the market opened Monday as $0.77 in earnings per share and $481 in revenue which beat out consensus estimates. On the heels of this…
Chris Lange These are the top analyst upgrades and downgrades featured by 24/7 Wall St. for Thursday, October 16, 2014.
